GLO1 upregulation has been described in the context of metabolic and inflammatory stress in vitro and in vivo [17,18,19,20], serving as a cellular mechanism to detoxify high levels of MG, particularly in cancer, where high glycolytic rates as a result of the Warburg effect are observed. The gene discussed is GLO1; the disease is cancer.